| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7534430 |
Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
May. 19, 2009 |
| 7534426 |
Glutenase enzyme assays |
May. 19, 2009 |
| 7531516 |
Peptidic compounds selectively binding to P-selectin |
May. 12, 2009 |
| 7531513 |
Therapeutic preparation of very high purity FVIIa and method for obtaining same |
May. 12, 2009 |
| 7531509 |
Papillosin antimicrobial peptide, a gene coding said peptide, a vector, a transformed organism and a compound containing said organism |
May. 12, 2009 |
| 7531508 |
Splice variant of the human pituitary growth hormone |
May. 12, 2009 |
| 7531507 |
Acylated nonadepsipeptides containing pyridyl alanine residues |
May. 12, 2009 |
| 7531505 |
Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices |
May. 12, 2009 |
| 7531504 |
Pharmaceutical composition and method for inhibiting gastrointestinal inflammation |
May. 12, 2009 |
| 7531503 |
Cell scaffold matrices with incorporated therapeutic agents |
May. 12, 2009 |
| 7531502 |
Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
May. 12, 2009 |
| 7531501 |
Method of treating endothelial injury |
May. 12, 2009 |
| 7531500 |
Preventing airway mucus production by administration of EGF-R antagonists |
May. 12, 2009 |
| 7531183 |
Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
May. 12, 2009 |
| 7531173 |
Ophthalmic composition of a VEGF antagonist |
May. 12, 2009 |
| 7531172 |
Methods of treating diseases with a VEGF antagonist |
May. 12, 2009 |
| 7531004 |
Pliable conformable bone restorative |
May. 12, 2009 |
| 7528107 |
Methods of treating inflammation in mammalian tissues comprising administering human alpha-defensins |
May. 5, 2009 |
| 7528106 |
Compositions and methods for treatment of neovascular diseases |
May. 5, 2009 |
| 7528105 |
Heterodimeric chain synthetic heparin-binding growth factor analogs |
May. 5, 2009 |
| 7528104 |
Peptides that bind to the erythropoietin receptor |
May. 5, 2009 |
| 7527954 |
Method for in vitro evolution of polypeptides |
May. 5, 2009 |
| 7527802 |
Vaccine for transcutaneous immunization |
May. 5, 2009 |
| 7527797 |
Vibrio cholerae 0139 conjugate vaccines |
May. 5, 2009 |
| 7524821 |
Scaffolded maleimide clusters for multivalent peptide assembly |
Apr. 28, 2009 |
| 7524815 |
Osteoprotegerin in milk |
Apr. 28, 2009 |
| 7524813 |
Selectively conjugated peptides and methods of making the same |
Apr. 28, 2009 |
| 7524812 |
Pharmaceutical formulation comprising ziconotide |
Apr. 28, 2009 |
| 7524811 |
Anti-angiogenic peptides from the N-terminus of endostatin |
Apr. 28, 2009 |
| 7524810 |
Modified Cry34 proteins |
Apr. 28, 2009 |
| 7524513 |
Biofunctional fibers |
Apr. 28, 2009 |
| 7524505 |
Compositions and methods for dual therapies of hair graying and balding in follicular delivery systems |
Apr. 28, 2009 |
| 7524499 |
Modified chimeric polypeptides with improved pharmacokinetic properties |
Apr. 28, 2009 |
| 7521422 |
Use of aspartic proteases in cosmetics and therapeutics |
Apr. 21, 2009 |
| 7521416 |
D-amino acid peptides |
Apr. 21, 2009 |
| 7521415 |
Methods of intracellular peptide delivery |
Apr. 21, 2009 |
| 7521068 |
Dry powder aerosols of nanoparticulate drugs |
Apr. 21, 2009 |
| 7521049 |
Use of VEGF inhibitors for treatment of eye disorders |
Apr. 21, 2009 |
| 7517870 |
Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovasc |
Apr. 14, 2009 |
| 7517856 |
Bioconjugates comprising sulfated polysaccharides and their uses |
Apr. 14, 2009 |
| 7517849 |
Inhibition of ABC transporters by transmembrane domain analogs |
Apr. 14, 2009 |
| 7517667 |
Methods for promoting, inhibiting and detecting toxin entry into cells |
Apr. 14, 2009 |
| 7517533 |
Pseudomonas aeruginosa antigens |
Apr. 14, 2009 |
| 7517530 |
Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency comprising administration of IGF-1 and growth hormone |
Apr. 14, 2009 |
| 7517528 |
Method and composition for treating skin wounds with epidermal growth factor |
Apr. 14, 2009 |
| 7514403 |
Process for the stabilization of proteins in an aqueous solution comprising cysteine in a concentration between 150 and 220mM |
Apr. 7, 2009 |
| 7514402 |
Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
Apr. 7, 2009 |
| 7514401 |
Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
Apr. 7, 2009 |
| 7514400 |
Synthetic mimics of mammalian cell surface receptors: method and compositions |
Apr. 7, 2009 |
| 7514399 |
Bonding tissues and cross-linking proteins with naphthalimide compounds |
Apr. 7, 2009 |
|
|
|
